Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
The case in front of me: SSA · Wuhan · Spain. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement…
What I am working with: VendorInvestigate · survodutide. I have read the obvious sources and they disagree with each other, so I would rather ask people who have…
The particulars: dulaglutide · Medutest. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
Conditions: Guangzhou · Japan. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
Details up front: method section · Homopeptide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
I am comparing a supplier certificate against an independent result on the same lot. I have read the primary source rather than the summary, which has left me with…
I have continuous temperature data for the period in question, which is unusual and I would like to use it. I am asking for verification rather than opinion, ideally…
The case in front of me: semaglutide · minus 20 °C. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at…
I have continuous temperature data for the period in question, which is unusual and I would like to use it. I would rather over-plan the first cycle and simplify…
Details up front: 95.2% · dulaglutide. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would…
The specifics, since they change the answer: 15 mg · ecnoglutide. I understand the observation; what I do not understand is the mechanism behind it. I have read the…
The specifics, since they change the answer: 98.2% · survodutide · WWB. I am at the decision point and I would rather think it through than improvise. I would rather…
What I am working with: orforglipron · mazdutide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
Stated plainly: 99.1% · mazdutide. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it seems…
The specifics, since they change the answer: a U-100 insulin syringe · 2 mg · 2 mg/mL. I would rather understand the derivation than memorise the outcome. Two people…
The specifics, since they change the answer: minus 20 °C · survodutide. Somebody stated this to me confidently and I would like to check it before repeating it. I…
Scale weight, waist circumference and a repetition maximum, all logged weekly. I would like help reading this properly rather than being told what conclusion to…
Conditions: orforglipron · phosphate-buffered diluent. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
I would like to know how much of this is established and how much is a reasonable story. I understand the observation; what I do not understand is the mechanism…
Setup, so nobody has to ask: SURMOUNT-1 · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three…
What I am working with: FGP · mazdutide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all citing each…
The case in front of me: 1 mg/mL · liraglutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works;…
The specifics, since they change the answer: tirzepatide · 40 °C. Somebody stated this to me confidently and I would like to check it before repeating it. I would…
This is the third vial from the same lot, so I can compare against two known-good ones. I suspect the usual explanation for this is wrong, or at least incomplete. I…